Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Additive effects of raloxifene and alendronate on bone density and biochemical markers of bone remodeling in postmenopausal women with osteoporosis.

Johnell, Olof LU ; Scheele, Wim H ; Lu, Yili ; Reginster, Jean-Yves ; Need, Allan G and Seeman, Ego (2002) In Journal of Clinical Endocrinology and Metabolism 87(3). p.92-985
Please use this url to cite or link to this publication:
author
; ; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Non-U.S. Gov't, Osteoporosis, Bone Density: drug effects, Biological Markers: blood, Alendronate: therapeutic use, Aged, Bone Remodeling: drug effects, Lumbar Vertebrae: drug effects, Human, Femur Neck: physiopathology, Femur Neck: drug effects, Female, Drug Synergism, Double-Blind Method, Collagen: antagonists & inhibitors, Bone Remodeling: physiology, Lumbar Vertebrae: physiopathology, Osteocalcin: antagonists & inhibitors, Middle Age, Postmenopausal: drug therapy, Postmenopausal: physiopathology, Peptides: antagonists & inhibitors, Raloxifene: therapeutic use, Selective Estrogen Receptor Modulators: therapeutic use, Support
in
Journal of Clinical Endocrinology and Metabolism
volume
87
issue
3
pages
92 - 985
publisher
Oxford University Press
external identifiers
  • scopus:0036963450
ISSN
1945-7197
language
English
LU publication?
yes
id
667a8443-1e3c-4175-9a28-6d8db4fef2f0 (old id 115518)
alternative location
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11889149&dopt=Abstract
date added to LUP
2016-04-01 16:34:55
date last changed
2022-03-30 08:52:09
@article{667a8443-1e3c-4175-9a28-6d8db4fef2f0,
  author       = {{Johnell, Olof and Scheele, Wim H and Lu, Yili and Reginster, Jean-Yves and Need, Allan G and Seeman, Ego}},
  issn         = {{1945-7197}},
  keywords     = {{Non-U.S. Gov't; Osteoporosis; Bone Density: drug effects; Biological Markers: blood; Alendronate: therapeutic use; Aged; Bone Remodeling: drug effects; Lumbar Vertebrae: drug effects; Human; Femur Neck: physiopathology; Femur Neck: drug effects; Female; Drug Synergism; Double-Blind Method; Collagen: antagonists & inhibitors; Bone Remodeling: physiology; Lumbar Vertebrae: physiopathology; Osteocalcin: antagonists & inhibitors; Middle Age; Postmenopausal: drug therapy; Postmenopausal: physiopathology; Peptides: antagonists & inhibitors; Raloxifene: therapeutic use; Selective Estrogen Receptor Modulators: therapeutic use; Support}},
  language     = {{eng}},
  number       = {{3}},
  pages        = {{92--985}},
  publisher    = {{Oxford University Press}},
  series       = {{Journal of Clinical Endocrinology and Metabolism}},
  title        = {{Additive effects of raloxifene and alendronate on bone density and biochemical markers of bone remodeling in postmenopausal women with osteoporosis.}},
  url          = {{http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11889149&dopt=Abstract}},
  volume       = {{87}},
  year         = {{2002}},
}